Evidence map›Paper›PMID 40156425›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2025

Investigating the Potential Synergistic Effects of Turmeric Extract and Black Rice Bran as Cytotoxic Agents Against HeLa Cells.

Rantika Silfarohana, Kuncara Nata Waskita, Nurul Hidayatul Mar'ah, Muhammad Saifur Rohman, Rizal Maarif Rukmana

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rantika SilfarohanaMaster Program of Biotechnology, Graduate School, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.ORCID 0009-0009-7837-0937
Kuncara Nata WaskitaThe College of Health Sciences Bhakti Husada Mulia, Taman Praja street No. 25, Taman district, Madiun, East Java, Indonesia.
Nurul Hidayatul Mar'ahThe College of Health Sciences Bhakti Husada Mulia, Taman Praja street No. 25, Taman district, Madiun, East Java, Indonesia.
Muhammad Saifur RohmanDepartment of Agricultural Microbiology, Faculty of Agriculture, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.ORCID 0000-0002-7764-9778
Rizal Maarif RukmanaResearch Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Cibinong, Bogor, Indonesia.ORCID 0000-0002-7175-4876

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the synergistic effect of extract combinations from turmeric and black rice bran extract as anticancer agents on HeLa cells.

methodsTurmeric and black rice bran extracts were obtained by maceration with 96% ethanol. To determine the IC50 and combination index values, the cytotoxic assay of the extracts on HeLa cells was evaluated using the MTT assay, individually or in combination. The LC-HRMS analysis was employed to profile each extract.

resultTurmeric and black rice bran extracts yielded 23.29% and 7.57%, respectively, and LC-HRMS revealed that turmeric extract has the most ar-turmerone at 10.4%. In contrast, black rice bran extract contains many fatty acid derivative compounds. The MTT assay showed that turmeric extract had an IC50 value of 54 µg/mL against HeLa cells, while black rice bran extract had an IC50 value of 446 µg/mL. Combining ½ IC50 of turmeric extract and ½ IC50 of black rice bran extract has a synergistic effect, resulting in a lower viable cell population of 43.04% compared to the individual treatment of turmeric and black rice bran extract, which resulted in 96.92% and 79.30%, respectively.

conclusionThis study showed that a combination of turmeric and black rice bran exhibits greater cytotoxic activity than the individual extracts, promising an alternative anticancer treatment, particularly for cervical cancer.

Indexed as

Antineoplastic Agents, PhytogenicCurcumaOryzaPlant ExtractsApoptosisCell ProliferationDrug SynergismHeLa CellsHumansAntineoplastic Agents, PhytogenicPlant Extractsturmeric extractblack rice branCervical cancercombination extractCytotoxicityTurmeric

Identifiers

PMID40156425
PMCPMC12174512

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.